Our Next Show: Looking Forward in 2022 for Multiple Myeloma with Robert Orlowski, MD, PhD, MD Anderson Cancer Center, Monday, Feb 7th @ 2 pm Central

UPCOMING MC RADIO SHOWS - January 28, 2022

Monday, February 7, 2022 @ Noon Pacific, 1 pm Mountain, 2 pm Central, 3 pm Eastern Call In by Phone to Listen Live: (347) 637-2631 or Lis... Read More

COVID Updates for the Multiple Myeloma Patient

LIFE WITH MYELOMA - January 26, 2022

A COVID update with Dr. Sundar Jagganath, Mount Sinai and Cynthia Chmielewski, HealthTree University Director New York City was an early a hotb... Read More

ASH 2021: One Step Closer to Chemo Free Living?

MYELOMA NEWS - January 26, 2022

Achieving a prolonged minimal residual disease (MRD) standard after consolidation may raise hope for a chemo-free future for patients who respond well to therap... Read More

Full Show: Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic

MC RADIO - January 25, 2022

Shaji Kumar, MD Mayo Clinic Interview Date: January 6, 2022 Thanks to our episode sponsor Summary We are familiar with monoclonal antibodies li... Read More

ASH 2021: New Interferon Alpha Myeloma Therapy for CD38-Refractory Multiple Myeloma Patients

MYELOMA NEWS - January 25, 2022

A new myeloma therapy with the crazy name Modakafusp Alfa (previously known as TAK-573) is showing positive impact for relapsed/refractory myeloma patients... Read More

Finding Free COVID Test For Medicare Beneficiaries

LIFE WITH MYELOMA - January 24, 2022

The Biden Administration's new mandate that insurers cover the cost of at-home test does not include beneficiaries of Medicare. This is very unfortunat... Read More

Motixafortide: A New Drug to Mobilize Stem Cells Prior to Stem Cell Transplant

LIFE WITH MYELOMA - January 21, 2022

Many of us, myeloma patients, are familiar with the process to mobilize stem cells [also known as CD34+ cells] prior to harvest (and subsequent infusion after t... Read More

Change is Possible: Achieve your Myeloma Goals in 2022 with the Help of a Myeloma Coach

MYELOMA COACH - January 20, 2022

The start of a brand new year feels fresh and inspiring. It's a clean slate, a new start. It’s no wonder that this is the time many commit to new... Read More

ASH 2021: Health Disparities Related to CAR-T Therapy in Myeloma

MYELOMA NEWS - January 20, 2022

CAR T studies continue to show a common trend of low participation rates of the black community in clinical trials. Blacks are very underrepresented in all... Read More

Full Show: Exploring Innovative Immunotherapy with Drs. Jim Allison and Pam Sharma

MC EVENTS - January 19, 2022

According to Dr. Jim Allison, the key to a cure to cancer can be found not in home runs, but in singles or doubles. During an intriguing hour-long inte... Read More

Full Show: Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD

MC RADIO - January 19, 2022

Dan Vogl, MD, University of Pennsylvania Yulia Nefedova, MD, PhD, Wistar Institute Interview Date: January 5, 2022 Thanks to o... Read More

ASH 2021: Remote Monitoring of Symptoms During Myeloma CAR T Therapy?

LIFE WITH MYELOMA - January 19, 2022

CAR T therapy will become a more broadly available multiple myeloma treatment in the near future, but one of the concerning side effects (cytokine release syndr... Read More

ASH 2021: Using BLENREP in Myeloma Combinations

MYELOMA NEWS - January 17, 2022

Updates on belantamab mafodotin (BLENREP) were presented at the recent ASH 2021 meeting, showing that it could be successfully combined with other standard... Read More

Find Myeloma Help